Regarding the last part of your post, I don’t think it

New Post Public Reply Private Reply Replies (3) Message Board
Katangolo My69z #142558
999
Regarding the last part of your post, I don’t think it was Dr Jay’s communications at all that resulted in “The Letter”: The previous blunders, amateur approaches and incomplete/mis-formatted BLA filings as well as blatantly ignoring the FDA warnings contributed. The bogus press releases and Proactive videos made anyone with knowledge of the rules that are expected in PhRMA/Biotech and regulatory affairs, cringe as they were so out of line with what can legally (jmo - not legal advice) be said from a company either developing a drug or one that has already been approved.

It is a very serious offense to misrepresent a drug before it has passed certain hurdles established by the FDA. That is not a slight whatsoever on the efficacy of LL and what we all were witnessing across multiple disease states. You just can’t use words like (these are my words)- Amazing, Better, Beautiful…; this is a standard (and bare minimum) understanding in the Industry and NP didn’t get that. The Amerex debacle made things terrible for LL to get approved.

Then there was a pitchforks and torches period where mob mentality ruled and cydy enthusiasts were pressing to write the FDA and demand approval, without LL having passed the proper regulatory hurdles. The FDA took this to mean thar NP ‘s premature and out of bounds languaging was getting through to the “Lay” (their word from the letter) and they have to take that seriously because it, again, Hadn’t gone through the proper regulatory process and cross the proper hurdles to obtain approval.

What is the letter harsh? Absolutely. Could it have been handled a different way? Absolutely. I disagree with many of the characterizations of LL in that letter, but the letter was not caused by Dr. Jay. It was years in the making from the fumblers of Amerex Along with the points that I have noted above.

*I again implore folks to let SA handle things.

Having said that I am 100% confident that Dr. Jay is the right man for the job and I say this because of the way he speaks. Like it or not, he has to be respectful of the FDA and he has to speak and write in a language that Does not trigger them. They are bureaucrats and they work under a system. That system has certain steps that must occur and If you step out of line, they will push back. Dr. Jay understands this and his experience in clinical trials and regulatory affairs of drug approvals are a godsend to our cause. His passion for improving, the lives of patience is a bonus to say the least.

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Anixa Expands Global Footprint with Aussie Patent

Updated Category News Views 3

Breaking New Ground in Cancer Immunotherapy Today feels like a pivotal day for Anixa Biosciences. Their announcement about securing a patent in Australia for their trailblazing breast cancer vaccine is like planting a flag on new, promising territory. This is no minor step; it's a strategic leap for the company as it strengthens its intellectual grip on the global...

Continue Reading
Lawsuit Targets Electrical Consultants' Labor Practices

Updated Category News Views 2

Trouble Brews at Electrical Consultants, Inc. Right on the heels of a long workday, some employees of Electrical Consultants, Inc. seem to be getting a double whammy. The company is tangled up in a class action lawsuit lodged by the well-known Blumenthal Nordrehaug Bhowmik De Blouw LLP. This ain't your everyday grievance, folks; we're talking meal and rest period...

Continue Reading
Nature-Based Solutions: The Economic And Community Impact

Updated Category News Views 5

Harnessing Nature to Boost Economies You ever stop to think about how nature itself might just be the best investment? Well, the Walton Family Foundation surely does, betting big on nature-based solutions. Their latest initiative, 'Human Nature,' is shedding light on how these solutions aren't just saving ecosystems — they're fortifying economies and enriching...

Continue Reading
Tenera Care's Tech Triumph: Halving Falls with Simplicity

Updated Category News Views 4

Every once in a while, a piece of tech comes along that makes you sit up and say, ‘Now that’s a game-changer!’ And with the recent rave reviews, Tenera Care seems to hit just that sweet spot for folks in the senior living game. By handing Dublin Glenn Memory Care the gold in the KISS category at the 2026 McKnight's Technology Awards, it’s clear the industry is...

Continue Reading
Lititz Mutual Embraces AI with Guidewire ProNavigator

Updated Category News Views 2

It's not every day you see a company like Lititz Mutual making moves in the artificial intelligence (AI) arena. Based out of Lititz, Pennsylvania, this insurance firm has decided to shake things up with Guidewire's ProNavigator AI assistant. Forging New Paths in Insurance Lititz Mutual is set to inject some serious tech into their operations. The goal? Make life easier...

Continue Reading
Castillo Engineering Gears Up with New VP Appointments

Updated Category News Views 1

New Leadership to Drive Expansion In a boost to its commitment to scaling up, Castillo Engineering, based in Maitland, Florida, has roped in two veterans from the renewables sector as vice presidents. Aaron Carrillo and Devin Radovich, who share a history of successful collaboration at Renewable Energy Systems Americas (RES), are set to guide Castillo's growth in the...

Continue Reading
Lavior and CR Fitness Team for Wellness Reach

Updated Category News Views 1

Botanical Care Meets Gym Life in the Southeast Lavior, the botanical whiz kids of wound and skin care out of Miami, are shaking hands with CR Fitness, Crunch's big-time franchise operator carrying the flag across the Southeast. They’ve ironed out a deal that’ll park Lavior’s products in more than 60 gyms covering Florida, Georgia, North Carolina, and Texas. It’s a...

Continue Reading
HNTB Expands in Capital Region: A Strategic Move

Updated Category News Views 1

Breaking New Ground in Arlington and Baltimore Deepening their stake in the Capital Region's future, HNTB has thrown open new office doors in Arlington, Virginia, and Baltimore, Maryland. We're not just talking fancy buildings, folks—this is about securing a piece of the infrastructure pie that's only going to get bigger and tastier. Infrastructure's the backbone of...

Continue Reading
Molex's VersaBeam Mini Pushes AI Data Center Limits

Updated Category News Views 2

Game-Changer for AI Data Centers? Across the tech landscape, space is a premium, and Molex's new VersaBeam Mini arrives like a hail Mary in the fourth quarter. In AI data centers, squeezing down every single component counts—especially when optical density's in play. What we're seeing here is a potential paradigm shift. A 3x density improvement from a tiny 3.5 x 9 mm...

Continue Reading
Annex Brands Grows with Bastrop's PostalAnnex Opening

Updated Category News Views 1

New PostalAnnex Location Opens in Bastrop, TX Here's a fresh chapter in the books for Annex Brands, Inc. They've just cut the ribbon on a brand spanking new PostalAnnex in Bastrop, Texas, handing the reins over to eager fresh faces, Chetan Modi and Karan Desai. And you know what? This ain't just any regular location. It's a one-stop-shop for anything you could need, from...

Continue Reading

Top 5 Most Recently Viewed Articles

Hyphens Pharma Partners with Louis Widmer to Launch Cerapro® MED

Updated Category News Views 107

Hyphens Pharma Collaborates with Louis Widmer for Cerapro® MED Hyphens Pharma International Limited is thrilled to announce a significant partnership with Louis Widmer SA for the commercialization of their innovative product, Cerapro® MED Skin Barrier Cream. This agreement enables Louis Widmer to promote and distribute Cerapro® MED in six European countries. About...

Continue Reading
Nurix Therapeutics to Present Promising Data on NX-5948

Updated Category News Views 185

Exciting Developments at Upcoming Conferences Nurix Therapeutics, Inc. (NASDAQ: NRIX), a pioneering biopharmaceutical company headquartered in San Francisco, California, is set to unveil new clinical data at prestigious scientific events. This company specializes in discovering and developing innovative medicines that target protein degradation, aiming to improve...

Continue Reading
Neuberger Berman Real Estate Fund Declares Monthly Dividend

Updated Category News Views 374

Neuberger Berman Real Estate Securities Income Fund Announces Dividend Neuberger Berman Real Estate Securities Income Fund Inc. (NYSE American: NRO) recently declared a distribution of $0.0312 per share, strengthening its commitment to delivering consistent returns to its shareholders. This latest declaration follows the fund’s established pattern of regular monthly...

Continue Reading
Exploring the Impact of Gold's Surge on Bitcoin's Value

Updated Category News Views 130

Exploring the Current Market Dynamics of Gold and Bitcoin In recent times, there has been a notable spike in gold prices, leading to discussions about Bitcoin's status as a reliable store of value. Investors are closely monitoring the trends, and current charts reveal a contrasting performance: while gold is experiencing a significant rise, Bitcoin's value has started to...

Continue Reading
The Future of Power Purchase Agreements: Market Growth Insights

Updated Category News Views 494

Understanding the Power Purchase Agreement Market Dynamics The Power Purchase Agreement (PPA) market is on an exciting trajectory, predicted to soar to USD 7,652.3 billion by 2034 according to recent insights from Dimension Market Research. This significant growth reflects a compound annual growth rate (CAGR) of 32.8% from 2025 onwards, indicating a robust and expanding...

Continue Reading